These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 15705407)
21. Premature ovarian failure: steroid synthesis and autoimmunity. Doldi N; Belvisi L; Bassan M; Fusi FM; Ferrari A Gynecol Endocrinol; 1998 Feb; 12(1):23-8. PubMed ID: 9526706 [TBL] [Abstract][Full Text] [Related]
22. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344 [TBL] [Abstract][Full Text] [Related]
23. Plasma androgen concentrations and risk of incident ovarian cancer. Tworoger SS; Lee IM; Buring JE; Hankinson SE Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156 [TBL] [Abstract][Full Text] [Related]
24. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078 [TBL] [Abstract][Full Text] [Related]
25. Reference ranges of 17-hydroxyprogesterone, DHEA, DHEAS, androstenedione, total and free testosterone determined by TurboFlow-LC-MS/MS and associations to health markers in 304 men. Damgaard-Olesen A; Johannsen TH; Holmboe SA; Søeborg T; Petersen JH; Andersson A; Aadahl M; Linneberg A; Juul A Clin Chim Acta; 2016 Feb; 454():82-8. PubMed ID: 26765096 [TBL] [Abstract][Full Text] [Related]
26. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess. Wiebe RH; Morris CV Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743 [TBL] [Abstract][Full Text] [Related]
27. Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls. Elias AN; Pandian MR; Rojas FJ Gynecol Obstet Invest; 1997; 43(1):47-8. PubMed ID: 9015699 [TBL] [Abstract][Full Text] [Related]
28. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Salamalekis E; Bakas P; Vitoratos N; Eleptheriadis M; Creatsas G Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):16-9. PubMed ID: 16139944 [TBL] [Abstract][Full Text] [Related]
29. A steroid-cell tumor of the ovary resulting in massive androgen excess early in the gonadol steroidogenic pathway. Stephens JW; Fielding A; Verdaguer R; Freites O Gynecol Endocrinol; 2008 Mar; 24(3):151-3. PubMed ID: 18335330 [TBL] [Abstract][Full Text] [Related]
30. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes? Korytkowski MT; Krug EI; Daly MA; Deriso L; Wilson JW; Winters SJ Metabolism; 2005 Dec; 54(12):1626-31. PubMed ID: 16311096 [TBL] [Abstract][Full Text] [Related]
31. Serum anti-Müllerian hormone expression in women with premature ovarian failure. Méduri G; Massin N; Guibourdenche J; Bachelot A; Fiori O; Kuttenn F; Misrahi M; Touraine P Hum Reprod; 2007 Jan; 22(1):117-23. PubMed ID: 16954410 [TBL] [Abstract][Full Text] [Related]
32. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women. Elhassan YS; Idkowiak J; Smith K; Asia M; Gleeson H; Webster R; Arlt W; O'Reilly MW J Clin Endocrinol Metab; 2018 Mar; 103(3):1214-1223. PubMed ID: 29342266 [TBL] [Abstract][Full Text] [Related]
33. Daily variation of serum cortisol, 17-hydroxyprogesterone and five androgens in healthy women. Mikulecky M; Kreze A; Putz Z; Moravcik M Braz J Med Biol Res; 1995 Apr; 28(4):485-90. PubMed ID: 8520547 [TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione and testosterone in children determined by TurboFlow-LC-MS/MS. Søeborg T; Frederiksen H; Fruekilde P; Johannsen TH; Juul A; Andersson AM Clin Chim Acta; 2013 Apr; 419():95-101. PubMed ID: 23453988 [TBL] [Abstract][Full Text] [Related]
35. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378 [TBL] [Abstract][Full Text] [Related]
36. Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling. Mezzullo M; Fazzini A; Gambineri A; Di Dalmazi G; Mazza R; Pelusi C; Vicennati V; Pasquali R; Pagotto U; Fanelli F Clin Chem Lab Med; 2017 Aug; 55(9):1315-1323. PubMed ID: 28076306 [TBL] [Abstract][Full Text] [Related]
37. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Hartmann BW; Kirchengast S; Albrecht A; Laml T; Söregi G; Huber JC Gynecol Obstet Invest; 1997; 44(2):127-31. PubMed ID: 9286728 [TBL] [Abstract][Full Text] [Related]
38. Alterations in DHEA metabolism in schizophrenia: two-month case-control study. Ritsner M; Gibel A; Ram E; Maayan R; Weizman A Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994 [TBL] [Abstract][Full Text] [Related]
39. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids. Dayal M; Sammel MD; Zhao J; Hummel AC; Vandenbourne K; Barnhart KT J Womens Health (Larchmt); 2005 Jun; 14(5):391-400. PubMed ID: 15989411 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure. Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]